Company invites individual and institutional investors to log-on to VirtualInvestorConferences.com to view presentation
SAN RAMON, Calif., Dec. 5, 2016 /CNW/ -- Galena Biopharma Inc. (NASDAQ: GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs, today announced that the December 1, 2016 presentation from Mark W. Schwartz, Ph.D., President and Chief Executive Officer, is now available for on-demand viewing at VirtualInvestorConferences.com.
Galena Biopharma Inc.'s presentation will be available for 90 days. Interested parties may download shareholder materials from the "virtual trade booth" for the next three weeks.
Learn more about the event at www.VirtualInvestorConferences.com.
About Galena Biopharma Inc.
Galena Biopharma Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs. Galena's pipeline consists of multiple mid-to-late-stage clinical assets led by our hematology asset, GALE-401, and our novel cancer immunotherapy programs including NeuVax™ (nelipepimut-S), and GALE-301/GALE-302. For more information, please visit our website at https://galenabiopharma.com/
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
Logo - http://photos.prnewswire.com/prnh/20160129/327291LOGO
SOURCE Galena Biopharma Inc.
For further information: Galena Biopharma, Inc., Remy Bernarda, SVP, Investor Relations & Corporate Communications, (925) 498-7709, firstname.lastname@example.org; VirtualInvestorConferences.com, Bradley H. Smith, Director of Marketing, IR and Compliance Services, PR Newswire, +1.201.947.7157, email@example.com, http://galenabiopharma.com